Are you looking to build an effective biotech team? On next week's Tuesday Talks, Shalabh Gupta, MD, founder and CEO of Unicycive Therapeutics, will join us to share his unique journey of taking his biotech company public with just one employee. Dr. Gupta will also discuss why building a strong, cohesive team may be the key to long-term success in the biotech industry. This is a not-to-miss episode for all new founders and entrepreneurs. Register today! #linkedinlive #entrepreneurship #teambuilding
About us
Cure is a vibrant healthcare innovation campus in the heart of New York City with a mission to advance health. Supporting healthcare and life science entrepreneurs, Cure offers digital and in-person content, programming, and learnings on critical health and business topics. The campus at 345 Park Avenue South features laboratory and business facilities, office space and premium event venues, including an education center, conference center, and iconic rooftop terrace. Residents and members collaborate across the spectrum of healthcare and focus on diagnostic, device, drug development and production as well as care delivery and public health. For more information, please visit wewillcure.com.
- Website
-
www.wewillcure.com
External link for Cure.
- Industry
- Health and Human Services
- Company size
- 11-50 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Founded
- 2020
- Specialties
- Life Science, Incubator, Fellowships, healthcare, scientists, doctors, researchers, digitalhealth, science, health, startup, doctors , ecosystems, business, AI, education, cancer, entreprenuer, health equity, access to care, global health, artificial intelligence, events, and start-ups
Locations
-
Primary
Get directions
345 Park Ave S
New York, NY 10010, US
Employees at Cure.
-
David Ewing Duncan
Journalist, Author, Researcher, Curator, and Advisor
-
Lauren Ruotolo
Creative Media Partnerships & Executive Producer | Keynote Speaker | Disability Advocate
-
Paul Oestreicher
Strategic Communications; Public and Media Relations; Risk/Issues/Crisis/Reputation Management; Thought Leader; Mentor, and Trusted…
-
Charles Kim
COO & CFO | Healthcare, Sustainability, Food & Beverage
Updates
-
Excitement is in the air at Cure this week as we are hosting #BioFuture2024! Today, Cure CEO Seema Kumar kicked off the week with Demy-Colton CEO & Founder, Sara Jane Demy, by introducing the renowned MIT computational biology professor Manolis Kellis. In a thought-provoking fireside chat journalist David Ewing Duncan and Kellis took a deep look into the real-world impact of #AI in science, exploring whether it can live up to its hype and how it might reshape the work academics have refined for centuries. Stay tuned all week for exclusive content and video at www.wewillcure.com from #biofuture2024!
-
-
Last week, Cure proudly partnered with Life Science Cares New York to bring high school students from across NYC together for the second annual Life Sciences Day, in collaboration with the New York City Economic Development Corporation. Students who joined us at Cure experienced hands-on experiment workshops and enjoyed networking lunches with leaders from our Cure resident companies, including Wandercraft, Deerfield Catalyst, Excelsior Sciences, Advancium Health Network, Evommune and Lexeo Therapeutics. At Cure, we believe in the power of the next generation to drive healthcare innovation. As our CEO, Seema Kumar, says: “The future of healthcare innovation lies in the hands of the next generation. Events like Life Sciences Day provide students with the invaluable opportunity to see firsthand how science can transform lives and how their passion and creativity can shape the future.” Thank you to everyone who contributed to this amazing day! Together, we’re inspiring tomorrow’s stem leaders. #NextGenInnovators #STEMEducation #HealthcareInnovation
-
We are thrilled to announce that Seema Kumar, CEO of Cure, has joined the board of Life Science Cares New York. Seema has been a lifelong champion for science and technology, women’s empowerment, and equity. From her early work at Johns Hopkins Medicine, The National Institutes of Health and the prestigious Whitehead Institute to her leadership roles at Johnson & Johnson and now as CEO of Cure, Seema continues to be a driving force for entrepreneurship, collaboration and community building across the life sciences sector, convening leaders who are creating life-changing solutions in healthcare. Through her new role on the board of Life Science Cares New York, she is eager to work with NYC's dynamic life sciences community to spur entrepreneurship, address the underserved and improve the lives of children in the city. #wewillcure #lifesciencecares
Seema’s career in life sciences is significant in helping drive equity & access to all. From her early work with the NIH and the prestigious Whitehead Institute to her leadership roles at Johnson & Johnson, Seema Kumar has been a driving force in championing science, advancing scientific innovation and creating impactful global health initiatives. During her time at J&J, she played a pivotal role in launching programs that fostered collaboration between science, government, and public health sectors, all with the aim of improving health equity and access to healthcare for underserved communities. Now, as CEO of Cure., Seema continues to build on that legacy, by driving collaboration and convening leaders who are creating life-changing solutions in healthcare. Through her new role on the board of Life Science Cares New York, she is eager to work with NYC's dynamic life sciences community to address poverty and improve the lives of children in the city. Please join us in welcoming Seema to this impactful organization! #LIfeScienceCaresNY #Cure
-
-
Healthcare programs, policy, and pricing are on the ballot for the 2024 US presidential election, where Americans will vote in only 12 days. Learn more from Rick Weissenstein, Managing Director at TD Cowen Inc., who shared his insights on Tuesday Talks about how the outcome of the US presidential election could shape the healthcare policy and innovation landscape.
-
At Cure, we have one goal: to Cure, period. #ICYMI, our live broadcast of Tuesday Talks with Kristen Dahlgren, please watch here: https://lnkd.in/eZXicFG2 and for more on the Cancer Vaccine Coalition https://lnkd.in/evAdNuuh #wewillcure #breastcancer #vaccines
Yesterday I had the pleasure of hosting Kristen Dahlgren a former NBC News and NBC Today Show correspondent, award-winning journalist, and #cancersurvivor turned entrepreneur who is now the Founder and CEO of the Cancer Vaccine Coalition. During our live broadcast of #TuesdayTalks at Cure., we explored a topic that affects millions of women worldwide: #breastcancer. We know the stats—that 1 in 8 women will be diagnosed with breast cancer in their lifetime--but we've grown numb to it. It’s a staggering number that Kristen is determined to change. Kristen not only beat breast cancer, but has embarked on a bold mission to cure cancer, founding a groundbreaking initiative to accelerate vaccines that may be the answer to a cancer-free world. In January, she launched the Cancer Vaccine Coalition, bringing experts from leading institutions such as Memorial Sloan Kettering Cancer Center the Cleveland Clinic, MD Anderson Cancer Center Dana-Farber Cancer Institute, and others to accelerate #cancervaccines currently in development across the #UnitedStates. We are at a tipping point for cancer vaccines she says: 1) We know the type of immune response needed, to kill cancer. 2) We know which parts of a cancer can stimulate the immune system. 3) New vaccine technology makes immunization more effective. Kristen says #vaccines may be the only way to kill every #cancer cell and eliminate breast cancer. We were able to accelerate them during the #pandemic, so why not now, she asks. And, unlike during the pandemic, cancer vaccines will not need to be mandated. They can be an option for anyone who is unwilling to settle for today’s less than desirable standard of care, she says. For more information on Kristen and the Cancer Vaccine Coalition, and to watch a replay of the Tuesday Talk go to www.wewillcure.com #healthcare #innovation #wewillcure #cancer #vaccines #pipeline #coalitions #endgoal #pandemic #womenshealth #women #breastcancer #breastcancerawarness #pink
-
-
Next week on Tuesday Talks our guest, Kristen Dahlgren, is a breast cancer survivor and former Today Show host. We will delve into how, during her breast cancer recovery, she refocused her personal and professional life to become the Founder & CEO of the Cancer Vaccine Coalition to bring a breast cancer vaccine to the market effectively within 5 to 10 years. #breastcancer
Empowered: From Survivor to CEO
www.linkedin.com
-
We will be live with Kristen Dahlgren in one hour. If you haven't registered, please do here: https://lnkd.in/esWtZpNX
Next week on Tuesday Talks our guest, Kristen Dahlgren, is a breast cancer survivor and former Today Show host. We will delve into how, during her breast cancer recovery, she refocused her personal and professional life to become the Founder & CEO of the Cancer Vaccine Coalition to bring a breast cancer vaccine to the market effectively within 5 to 10 years. #breastcancer
Empowered: From Survivor to CEO
www.linkedin.com
-
Last week, the FDA hosted a public meeting to discuss its recently announced Rare Disease Innovation Hub, an initiative designed to expedite the development and approval of new treatments for patients with rare diseases. Read more about what Grant W Mitchell, MD, MBA, Co-founder and CEO of Every Cure, hopes for the Rare Disease Innovation Hub. https://lnkd.in/eEgtzMsr #rarediseases #wewillcure
Every Cure’s Grant Mitchell on Hopes and Challenges for the FDA’s New Rare Disease Hub
wewillcure.com
-
This week at Cure, Aspen Institute Science & Society Program's Executive Director Aaron F. Mertz, Ph.D., spoke on a panel with Cure CEO Seema Kumar, Senior Advisor at Aspen Institute Business & Society Program, Cary Funk, and award-winning science communicator and writer Corey Powell about the future of science in healthcare. The panelists discussed maximizing the impact of science and health research and policy investments that could significantly help improve societal well-being in the U.S. and globally. Learn more about this event, The Aspen Institute's mission, and recent milestone activities to address pressing science-society challenges through collaboration, education, and global outreach. https://lnkd.in/dHCHUfvN
Aspen Institute Science & Society Program on Future of Healthcare
wewillcure.com